ORBi: Detailled Reference

Article (Scientific journals)

Comment estimer la filtration glomérulaire dans le contexte de l’adaptation posologique de médicaments ?

DELANAYE, Pierre; BOUQUEGNEAU, Antoine; Moranne, Olivier et al.

2020 • In Revue Médicale Suisse, 16 (703), p. 1489-1493

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/252157

PubMed
32852169

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

DelanayeRevMedSuisse2020.pdf

Publisher postprint (147.19 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] In chronic kidney disease (CKD) patients, the dosage of many medications should be adapted according to the glomerular filtration rate (GFR). GFR estimation is obtained by using creatinine-based equations. Many different equations have been proposed in the literature, and they don't systematically lead to the same result in terms of drug dosage. There is an ongoing debate to determine which equations should be recommended, with the Cockcroft equation on one side and the MDRD (« Modified Diet in Renal Diseases ») or CKD-EPI (« Chronic Kidney Disease Epidemiology ») on the other side. The last two equations are especially used by nephrologists whereas the Cockcroft is still considered by geriatrists and pharmacologists. In the current article, we discuss the pro/cons from both sides, and propose recommendation for the clinical practice.

Disciplines :

Urology & nephrology
Laboratory medicine & medical technology

Author, co-author :

DELANAYE, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de néphrologie

BOUQUEGNEAU, Antoine ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de néphrologie

Moranne, Olivier

Cavalier, Etienne ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale

Language :

French

Title :

Comment estimer la filtration glomérulaire dans le contexte de l’adaptation posologique de médicaments ?

Alternative titles :

[en] How to estimate glomerular filtration rate in the context of drug dosage adaptation ?

Publication date :

2020

Journal title :

Revue Médicale Suisse

ISSN :

1660-9379

Publisher :

Medecine et Hygiène, Switzerland

Volume :

16

Issue :

703

Pages :

1489-1493

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 04 November 2020

Statistics

Number of views

102 (6 by ULiège)

Number of downloads

15 (5 by ULiège)

More statistics

Scopus citations^®

0

Scopus citations^®
without self-citations

0

OpenAlex citations

0

Bibliography

Salvi F, Marchetti A, D’Angelo F, et al. Adverse drug events as a cause of hospitalization in older adults. Drug Saf 2012;35(Suppl 1):29-45.
Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 2017;73:759-70.
Roux-Marson C, Baranski JB, Fafin C, et al. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatr 2020;20:87.
Helldén A, Bergaman U, von Euler M, et al. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging 2009;26:595-606.
*Laville SM, Metzger M, Stengel B, et al. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort. Br J Clin Pharmacol 2018;84:2811-23.
Verbeeck RK, Musuamba FT. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol 2009;65:757-73.
*Dreisbach AW, Flessner MF. Drug metabolism and chronic kidney disease. In: Kimmel PL, Rosenberg, ME. Chronic Renal Disease. Oxford: Elsevier; 2014. p. 674-81.
*Zimner-Rapuch S, Amet S, Janus N, Deray G, Launay-Vacher V. Adaptation posologique chez les patients insuffisants rénaux chroniques et évaluation de la fonction rénale: focus sur les patients en cardiologie. Ann Cardiol Angeiol (Paris) 2015;64:1-8.
Barreto EF, Rule AD, Murad MH, et al. Prediction of the renal elimination of drugs with cystatin C vs creatinine: a systematic review. Mayo Clinic Proc [En ligne] 2019;94(3):500-14. Disponible sur: doi.org/10.1016/j.mayocp.2018.08.002.
Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38:1933-53.
Delanaye P, Cavalier E, Maillard N, et al. La créatinine: d’hier à aujourd’hui. Ann Biol Clin (Paris) 2010;68:531-43.
Soveri I, Berg UB, Björk J, et al. Measuring GFR: a systematic review. Am J Kidney Dis 2014;64:411-24.
*KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3:1-150.
Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
Pottel H, Hoste L, Dubourg L, et al. An estimating glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 2016;31:798-806.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
Levey AS, Stevens LA, Hostetter T. Automatic reporting of estimated glomerular filtration rate-just what the doctor ordered. Clin Chem 2006;52:2188-93.
Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005;16:763-73.
Verhave JC, Gansevoort RT, Hillege HL, et al. Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. J Am Soc Nephrol 2004;15:1316-22.
Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med 2014;52:815-24.
Gaspari F, Ruggenenti P, Porrini E, et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 2013;84:164-73.
Bouquegneau A, Vidal-Petiot E, Vrtovsnik F, et al. Modification of Diet in Renal Disease versus Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in obese patients. Nephrol Dial Transplant 2013;28(Suppl 4):iv122-30.
Lemoine S, Guebre-Egziabher F, Sens F, et al. Accuracy of GFR estimation in obese patients. Clin J Am Soc Nephrol 2014;9:720-7.
Evans M, van Stralen KJ, Schön S, et al. Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrol Dial Transplant 2013;28:2518-26.
Luis-Lima S, Escamilla-Cabrera B, Negrín-Mena N, et al. Chronic kidney disease staging with cystatin C or creatinine-based formulas: flipping the coin. Nephrol Dial Transplant 2019;34:287-94.
Porrini E, Ruggenenti P, Luis-Lima S, et al. Estimated GFR: time for a critical appraisal. Nat Rev Nephrol 2019;15:177-90.
Björk J, Grubb A, Sterner G, Nyman U. Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort. Scand J Clin Lab Invest 2011;71:232-9.
Pottel H, Björk J, Bökenkamp A, et al. Estimating glomerular filtration rate at the transition from pediatric to adult care. Kidney Int 2019;95:1234-43.
McConachie SM, Shammout L, Martirosov DM. Clearance confusion: an exploratory analysis of inpatient dosing discordances between renal estimating equations. Ann Pharmacother 2020;1060028020922492.
**Delanaye P, Flamant M, Cavalier E, et al. Adaptation posologique des médicaments et fonction rénale: quel(s) estimateur(s) faut-il choisir? Nephrol Ther 2016;12:18-31.
McFarland MS, Markley BM, Zhang P, Hudson JQ. Evaluation of Modification of Diet in Renal Disease Study and Cockcroft-Gault equations for sitagliptin dosing. J Nephrol 2012;25:515-22.
Delanaye P, Guerber F, Scheen A, et al. Discrepancies between the Cockcroft – Gault and Chronic Kidney Disease
Epidemiology (CKD-EPI) equations: implications for refining drug dosage adjustment strategies. Clin Pharmacokinet 2017;56:193-205.
Bouquegneau A, Vidal-Petiot E, Moranne O, et al. Creatinine-based equations for the adjustment of drug dosage in an obese population. Br J Clin Pharmacol 2016;81:349-61.
Dowling TC, Matzke GR, Murphy JE, Burckart GJ. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy 2010;30:776-86. 36 Berdougo J, Delorière É, Deray G, Launay-Vacher V. Clarification de la méthode utilisée pour adapter la posologie des médicaments chez les patients insuffisants rénaux: étude CLEAR. Nephrol Ther 2020;16:59-64.
Delanaye P, Cohen EP. Formula-based estimates of the GFR: equations variable and uncertain. Nephron Clin Pract 2008;110:c48-53.
Stevens LA, Manzi J, Levey AS, et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis 2007;50:21-35.
European Medicines Agency (EMA). Guideline on the evaluation of the pharmacokinetics of medicinal products in patients with decreased renal function. 2014. Disponible sur: www.ema.europa. eu/docs/en_GB/document_library/ Scientific_guideline/2014/02/ WC500162133.pdf.
Delanaye P, Mariat C, Cavalier E, Krzesinski JM. Indexation du débit de filtration glomérulaire par la surface corporelle: mythe et réalité. Nephrol Ther 2009;5:614-22.
Delanaye P, Krzesinski JM. Indexing of renal function parameters by body surface area: intelligence or folly? Nephron Clin Pract 2011;119:c289-92.
Food and Drug Administration (FDA). Guidance for Industry. Pharmacokinetics in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing and Labeling. 2010. Disponible sur: www.fda.gov/downloads/Drugs/Guidances/UCM204959.pdf.
Matzke GR, Aronoff GR, Atkinson Jr AJ, et al. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011;80:1122-37.
Agarwal R, Delanaye P. Glomerular filtration rate: when to measure and in which patients? Nephrol Dial Transplant 2019;34:2001-7.
Delanaye P, Melsom T, Ebert N, et al. Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol? Clin Kidney J 2016;9:700-4.

Similar publications